DK1520587T3 - Allergivaccinesammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf til allergibehandling - Google Patents

Allergivaccinesammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf til allergibehandling

Info

Publication number
DK1520587T3
DK1520587T3 DK03724819.2T DK03724819T DK1520587T3 DK 1520587 T3 DK1520587 T3 DK 1520587T3 DK 03724819 T DK03724819 T DK 03724819T DK 1520587 T3 DK1520587 T3 DK 1520587T3
Authority
DK
Denmark
Prior art keywords
allergy
preparation
vaccine composition
treatment
allergy treatment
Prior art date
Application number
DK03724819.2T
Other languages
English (en)
Inventor
Rosado Alexis Labrada
Lastre Jorge Ernesto Perez
Granada Gustavo Rafael Bracho
Lastre Dainerys Aleida Perez
Ramos Elisa Facenda
Vignier Caridad Zayas
Gonzalez Miriam De San Juan Lastre
Martin Oliver German Perez
Martinez Igor Bidot
Campo Alonso Judith Monica Del
Martinez Claudio Rodriguez
Gonzalez Victoriano Gustavo Sierra
Original Assignee
Inst Finlay Ct De Investigacion Produccion De Vacunas Y Sueros
Ct Nac Biopreparados
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Finlay Ct De Investigacion Produccion De Vacunas Y Sueros, Ct Nac Biopreparados filed Critical Inst Finlay Ct De Investigacion Produccion De Vacunas Y Sueros
Application granted granted Critical
Publication of DK1520587T3 publication Critical patent/DK1520587T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6018—Lipids, e.g. in lipopeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK03724819.2T 2002-05-08 2003-05-08 Allergivaccinesammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf til allergibehandling DK1520587T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20020091A CU22983A1 (es) 2002-05-08 2002-05-08 Composición vacunal contra las alergias y método para su obtención y empleo en el tratamiento de las mismas
PCT/CU2003/000007 WO2003094964A1 (es) 2002-05-08 2003-05-08 Composición vacunal contra las alergias, método para su obtención y empleo en el tratamiento de las mismas

Publications (1)

Publication Number Publication Date
DK1520587T3 true DK1520587T3 (da) 2011-10-17

Family

ID=34916998

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03724819.2T DK1520587T3 (da) 2002-05-08 2003-05-08 Allergivaccinesammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf til allergibehandling

Country Status (15)

Country Link
US (1) US7648709B2 (da)
EP (1) EP1520587B1 (da)
KR (1) KR101058350B1 (da)
CN (1) CN100540052C (da)
AR (1) AR039982A1 (da)
AT (1) ATE514431T1 (da)
AU (1) AU2003229258A1 (da)
BR (1) BR0309901A (da)
CU (1) CU22983A1 (da)
DK (1) DK1520587T3 (da)
ES (1) ES2368731T3 (da)
MX (1) MXPA04011070A (da)
MY (1) MY146106A (da)
PT (1) PT1520587E (da)
WO (1) WO2003094964A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23420A1 (es) * 2003-12-30 2009-09-08 Univ De Cambridge Proteoliposomas y sus derivados como adyuvantes inductores de respuesta citotóxica y las formulaciones resultantes
EP1872792A1 (en) * 2006-06-29 2008-01-02 Biotech Tools S.A. A method for the production of hydrolyzed allergen
ZA200900899B (en) * 2006-08-07 2010-07-28 Harvard College Protein matrix vaccines and methods of making and administering such vaccines
EP2042193A1 (en) * 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
WO2009083589A1 (en) * 2008-01-02 2009-07-09 Biotech Tools S.A. Pharmaceutical formulation for allergen preparation
CU20080215A7 (es) * 2008-11-19 2012-06-21 Inst Finlay Vacunas unitemporales
KR101413844B1 (ko) * 2008-12-09 2014-06-30 화이자 백신스 엘엘씨 ＩｇＥ ＣＨ３ 펩티드 백신
CU20100083A7 (es) 2010-05-05 2012-06-21 Inst Finlay Tolerogenos adyuvados como vacuna de malaria
CN101972472A (zh) * 2010-10-26 2011-02-16 北京新华联协和药业有限责任公司 一种变应原疫苗纯化及其制备的方法
CU20110202A7 (es) 2011-11-02 2013-12-27 Inst Finlay Ct De Investigación Producción De Sueros Y Vacunas Composición inmunogénica de polisacáridos planos adyuvados y las formulaciones resultantes
EP2689775A1 (en) 2012-07-25 2014-01-29 Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros Cochleate with only one mamp
CN110624101A (zh) * 2018-06-22 2019-12-31 江苏众红生物工程创药研究院有限公司 重组尘螨变应原蛋白药物合剂及其应用
CN112023062A (zh) * 2020-09-18 2020-12-04 北京基因安科技有限公司 一个用可溶性IgE受体抑制过敏反应的方法
IT202200011459A1 (it) * 2022-05-31 2023-12-01 Anallergo S P A Uso della ultrafiltrazione per la produzione di estratti allergenici purificati

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695694A (en) 1986-02-14 1987-09-22 Fusion Systems Corporation Structure for minimizing microwave leakage
RU2023448C1 (ru) * 1987-07-30 1994-11-30 Сентро Насьональ Де Биопрепарадос Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в
US5834015A (en) * 1996-09-11 1998-11-10 Albany Medical College Protein-lipid vesicles and autogenous vaccine comprising the same
IT1318691B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche del gruppo 2 di dermatophagoides.
CA2438425C (en) * 2001-03-09 2012-05-01 Id Biomedical Corporation Of Quebec A novel proteosome-liposaccharide vaccine adjuvant

Also Published As

Publication number Publication date
ES2368731T3 (es) 2011-11-21
KR101058350B1 (ko) 2011-08-22
US7648709B2 (en) 2010-01-19
EP1520587B1 (en) 2011-06-29
EP1520587A1 (en) 2005-04-06
KR20050025175A (ko) 2005-03-11
MXPA04011070A (es) 2005-07-14
WO2003094964A1 (es) 2003-11-20
US20060110435A1 (en) 2006-05-25
CN1658900A (zh) 2005-08-24
MY146106A (en) 2012-06-29
ATE514431T1 (de) 2011-07-15
AR039982A1 (es) 2005-03-09
CN100540052C (zh) 2009-09-16
BR0309901A (pt) 2008-08-12
AU2003229258A8 (en) 2003-11-11
CU22983A1 (es) 2004-09-09
PT1520587E (pt) 2011-09-27
AU2003229258A1 (en) 2003-11-11

Similar Documents

Publication Publication Date Title
DK1539224T3 (da) Antimikrobielt præparat og fremgangsmåde til anvendelse
IS7977A (is) Samsetningar og aðferð til samsettra meðferðar
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
IS2540B (is) Afleiður af N-[fenýl(píperidín-2-ýl)metýl]bensamíð, aðferð við framleiðslu þeirra og notkun í læknismeðferðum
IS7684A (is) Ný efnasambönd, blöndur og aðferðir til að meðhöndla bólgusjúkdóma og -ástand
NO20053874L (no) Formulering og metoder for behandling av thrombocytemi
IS7966A (is) Pyrazól og aðferðir við að búa þau til og notkun þeirra
DK1330249T3 (da) Aripiprazol-lægemiddelstof med lav hygroskopicitet og fremgangsmåder til fremstilling deraf
NO20055204D0 (no) Derivater av piperidinyl- og pipemzinylalkylkarbamater, fremgangsmater for fremstilling derav og anvendelse av de samme i terapi
IS2878B (is) Arípíprazól-samsett lyfjaform og aðferð
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
IS7188A (is) Asabísýklísk-setin samtengd heteróarýl efnasambönd, aðferð til framleiðslu þeirra og notkun
IS2733B (is) Afleiður af díoxan-2-alkýlkarbamötum, framleiðsluaðferð þeirra, milliefni notuð við framleiðsluna, og notkun þeirra í meðferð.
DK1520587T3 (da) Allergivaccinesammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf til allergibehandling
DK1949936T3 (da) Sammensætning til kontrolleret frigivelse og fremgangsmåde til fremstilling deraf
DK1534514T3 (da) Materialer, der kan ånde, omfattende væv med ringe forlængelse og fremgangsmåder til fremstilling heraf
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
DK1590321T3 (da) Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DK1596868T3 (da) Fremgangsmåde til behandling af hjertesvigt og medikament dertil
NO20033123L (no) Terapeutisk hinne dannende sammensetning og behandlingsplan derav
DK1478438T3 (da) Fremgangsmåder og sammensætninger til behandling af astma
DK1783105T3 (da) Mørtelsammensætning, fremgangsmåde til fremstilling og anvendelse deraf
DK1556382T3 (da) 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
IS7424A (is) Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær
DK1696913T3 (da) Vinfluninholdigt farmaceutisk præparat til parenteral administration, fremgangsmåde til fremstilling deraf og dets anvendelse